A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pregabalin-Referenced, Parallel-Group, Adaptive Design Study of DVS SR [desvenlafaxine] in Adult Female Outpatients With Fibromyalgia Syndrome.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Pregabalin (Primary) ; Desvenlafaxine
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Wyeth
- 24 Feb 2010 Actual number of patients added to 125 as reported by ClinicalTrials.gov.
- 26 Nov 2008 Status changed from recruiting to discontinued, as reported in ClinicalTrials.gov record.
- 10 Jul 2008 New trial record.